FDA Inspection 1052872 — Natco Pharma Ltd. - Chemical Division
The FDA completed an inspection of Natco Pharma Ltd. - Chemical Division on February 16, 2018 in Rangareddy District. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rangareddy District (India)